MENU
electroCore LLC

In Your Practice

1. Become a gammaCore Certified Health Care Provider

gammaCore is only available by or on the order of a health care professional. electroCore offers a convenient training program designed to meet your educational needs to support the use of gammaCore in your practice. The training program can be completed online or with the assistance of an experienced gammaCore representative in your office. Click here to request access to the training portal or set up an appointment with a gammaCore representative.

2. Identify Appropriate Patients for Therapy

gammaCore is a non-pharmacologic treatment option that can be used both acutely and preventatively to manage chronic migraine and cluster headaches offering you the flexibility to design an individual treatment plan based on the patients headache frequency, symptom severity and co-morbid conditions. gammaCore can be used alone or in addition to other treatments. gammaCore should not be used by people with an implanted device such as a pacemaker, hearing aid implant, or any implanted electronic device. It should not be used in people who are diagnosed with narrowing of the arteries (carotid atherosclerosis) or those who have had surgery to cut the vagus nerve in their neck. Side effects may include hoarseness, shortness of breath, change in voice, & skin irritation. For full prescribing information, refer to the Instructions for Use.

The gammaCore device is intended for non-invasive vagus nerve stimulation on the side of the neck. gammaCore is indicated for the treatment and/or prevention of primary headache (Migraine, Cluster Headache, and Hemicrania Continua) and Medication Overuse Headache (MOH) in Adults. In Canada, the gammaCore device is intended for non-invasive stimulation of the vagus nerve in the neck. gammaCore is indicated for the acute and or/prophylactic treatment of cluster headache and treatment of migraine in adults.

3. Ordering Information

gammaCore is only available with a prescription and/or authorization form signed by a physician. Once completed, the patient can submit the form directly to electroCore for processing.

gammaCore is available as a pre-loaded treatment:

  • gammaCore 300 Dose Device

Each dose is active for 2 minutes (120 seconds) once turned on. Once the doses have been depleted, the device must be disposed of and replaced.

Click on one of the links below to print out the authorization form. Your patient may fax, mail or email the signed authorization form to electroCore for order processing.

Authorization & Order Forms to Download (PDFs)


English (Continental Europe)
Authorization_Form_EN_EU_tab
Patient_Order_Form_EU_EN_tab
Deutsch
Autorisierungsformular_tab
Patienten_Bestellformular_tab
Italiano
Modulo_di_autorizzazione_tab
Modulo_dordine_per_il_paziente_tab

Español
Formulario_de_autorizacion_tab
Formulario_de_pedido_del_paciente_tab
English (UK)
Authorisation_Order_Form_UK_tab
gammacore_doc_download_tab_white
English (Canada)
Authorization_Order_Form_Canada_tab
gammacore_doc_download_tab_white

Please email the signed authorization form to info@electrocorellc.com or fax to +49 2247 12 99870

4. Know What to Expect

In order to determine if a patient is a responder to treatment with gammaCore, an adequate trial is important. Most patients, when trained on the proper use of the device, will see a response within 3-5 acute attacks, and/or 4-8 weeks if using the gammaCore as a preventative therapy.

Live training resources are available to help your patients learn how to properly operate the gammaCore, and ensure they use the device appropriately and consistently, which will give your patient the best possible results. The service is free of charge and available to any gammaCore patient. Click Here to learn more about our patient support services and the electroCore patient promise.

OK